Search Within

Hematology-Oncology Fellows

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (17)
  3. Research Letter (3)
  4. Review (2)
Groups
  1. Molecular Imaging and Therapy Service (45)
  2. Radiology, Department of (45)
  3. Department of Medicine (44)
  4. Hematologic Malignancies, Division of (37)
  5. GME, Medicine (35)
  6. Graduate Medical Education (35)

More Groups

People
  1. Heiko Schoder (31)
  2. Gilles Salles (22)
  3. Maria Palomba (20)
  4. Alison Moskowitz (17)
  5. Andrew Zelenetz (16)
  6. Anita Kumar (16)

More People

Years
  1. 2025 (6)
  2. 2024 (9)
  3. 2023 (14)
  4. 2022 (5)
  5. 2021 (7)
  6. 2020 (4)
Publications
  1. Blood (10)
  2. Journal of Clinical Oncology (10)
  3. Clinical Cancer Research (3)
  4. Hematological Oncology (3)
  5. Blood Advances (2)
  6. Blood Cancer Journal (2)

More Publications

Publishers
  1. American Society of Hematology (12)
  2. American Society of Clinical Oncology (10)
  3. Nature Publishing Group (5)
  4. American Association for Cancer Research (3)
  5. Wiley Blackwell (3)
  6. Elsevier Inc. (2)

More Publishers

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
    Journal Article

    Raj, S. S.; Fei, T.; Fried, S.; Ip, A.; Fein, J. A.; Leslie, L. A.; Alarcon Tomas, A.; Leithner, D.; Peled, J. U.; Corona, M.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma
    Journal Article

    Luna, A.; Devlin, S. M.; Rejeski, K.; Flynn, J. R.; Corona, M.; Luttwak, E.; Rivas-Delgado, A.; Landego, I.; Cassanello, G.; Gomez-Llobell, M.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: Challenges and opportunities for clinical translation
    Review

    Morris, Z. S.; Demaria, S.; Monjazeb, A. M.; Formenti, S. C.; Weichselbaum, R. R.; Welsh, J.; Enderling, H.; Schoenfeld, J. D.; Brody, J. D.; McGee, H. M.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a first-in-class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-targeted CAR T-cell therapy for relapsed or refractory multiple myeloma: Updated analysis
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Chaudhari, J.; Hosszu, K.; Devlin, S.; Shah, U.; Landa, J.; McAvoy, D.; Lesokhin, A.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save